THOMAS APPIO - 25 Feb 2026 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
Chief Executive Officer, Director
Signature
/s/ Brianna M. Dorsi attorney-in-fact
Issuer symbol
BHC
Transactions as of
25 Feb 2026
Net transactions value
-$703,672
Form type
4
Filing time
27 Feb 2026, 17:12:14 UTC
Previous filing
11 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
APPIO THOMAS Chief Executive Officer, Director 400 SOMERSET CORPORATE BOULEVARD, BRIDGEWATER /s/ Brianna M. Dorsi attorney-in-fact 27 Feb 2026 0001683323

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Award $0 +815,425 +28% $0.000000 3,736,536 25 Feb 2026 Direct F1
transaction BHC Common Shares, No Par Value Tax liability $703,672 -116,502 -3.1% $6.04 3,620,034 26 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F2 This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.